Grignon D J, el-Naggar A, Ro J Y, Johnson D E, Ayala A G
Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
J Urol. 1989 Nov;142(5):1206-10. doi: 10.1016/s0022-5347(17)39030-4.
Deoxyribonucleic acid flow cytometry was applied retrospectively to 36 primary pure adenocarcinomas of the bladder, stages A through D. Six tumors were enteric, 3 mucinous, 11 signet ring, 3 papillary, 5 unspecified and 8 mixed. Eight tumors were urachal in origin and 28 were nonurachal. The deoxyribonucleic acid pattern was diploid in 12 cases, aneuploid in 19, tetraploid in 3 and uncertain in 2. Nineteen patients died of disease after a mean of 27.4 months, 7 were well at a mean of 73.9 months, 8 had died of an unrelated cause and 1 was alive with metastatic disease. Ploidy pattern did not correlate with tumor stage, histological pattern or type of outcome: 6 of 12 patients with diploid and 12 of 22 with nondiploid tumors died of disease. However, if the tumor was urachal 1 of 4 patients with a diploid pattern died of disease, while 3 of 4 with an aneuploid pattern either died or were alive with disease. Our data suggest that deoxyribonucleic acid ploidy pattern apparently is not a significant predictor of outcome for primary adenocarcinoma of the bladder except possibly when the origin is urachal.
对36例A至D期原发性膀胱纯腺癌进行了回顾性脱氧核糖核酸流式细胞术检测。6例肿瘤为肠型,3例为黏液型,11例为印戒型,3例为乳头状,5例未明确类型,8例为混合型。8例肿瘤起源于脐尿管,28例起源于非脐尿管。脱氧核糖核酸模式在12例中为二倍体,19例为非整倍体,3例为四倍体,2例不确定。19例患者平均27.4个月后死于疾病,7例平均73.9个月时情况良好,8例死于无关原因,1例有转移性疾病存活。倍体模式与肿瘤分期、组织学模式或转归类型无关:12例二倍体肿瘤患者中有6例死于疾病,22例非二倍体肿瘤患者中有12例死于疾病。然而,如果肿瘤起源于脐尿管,4例二倍体模式患者中有1例死于疾病,而4例非整倍体模式患者中有3例死于疾病或有疾病存活。我们的数据表明,脱氧核糖核酸倍体模式显然不是膀胱原发性腺癌转归的重要预测指标,可能起源于脐尿管的情况除外。